Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 6 May 2025 | 1 May 2025 |
Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 6th May 2025 at 03:00 P.M. at the registered office of the Company i.e. A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 inter alia to consider and approve agenda as mentioned in the intimation. Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Tuesday, 6th May, 2025 at the registered office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 03:00 P.M. and concluded at 06:40 P.M., inter-alia has, considered and approved: 1. Valuation report received from Mr. Manish Santosh Buchasia, Registered Valuer, Ahmedabad, having Registration No. IBBI/RV/03/2019/12235 has been obtained. 2. Decided to hold Extra-Ordinary General Meeting (EGM) of the Shareholders of the Company on Tuesday, 3rd June, 2025 at 03:00 P.M. through Video Conferences (VC) / Other Audio-Visual Means (OAVM). (As Per Bse Announcement Dated on :06.05.2025) | ||
Board Meeting | 29 Apr 2025 | 24 Apr 2025 |
Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2025 inter alia to consider and approve we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 29th April 2025 at 03:00 P.M. at the registered office of the Company inter alia to consider and approve the agenda as per attahed intimation. Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Tuesday, 29th April, 2025 at the registered office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 03:00 P.M. and concluded at 06:10 P.M., inter-alia has, considered and approved the agenda as mentioned in the attached outcome. (As per BSE Announcement Dated on 29/04/2025) | ||
Board Meeting | 25 Apr 2025 | 10 Apr 2025 |
Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/04/2025 inter alia to consider and approve Calling of Board Meeting on Friday 18th April 2025 at 03:00 P.M. Pursuant to regulation 30 and regulation 29 of the SEBI (Listing Obligations & Disclosure Requirement) 2015, we hereby inform you that Board of Directors in their meeting held on today, i.e. Friday, 18th April, 2025 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 3:00 P.M and concluded at 04:15 P.M. has decided to postponed and rescheduled the Board Meeting on Friday, 25th April, 2025 at 03:00 P.M., at the registered office of the Company to discuss and consider agenda mentioned in the attached file. Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and approve Pursuant to regulation 30 and regulation 29 of the SEBI (Listing Obligations & Disclosure Requirement) 2015, we hereby inform you that Board of Directors in their meeting held on today, i.e. Friday, 18th April, 2025 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 3:00 P.M and concluded at 04:15 P.M. has decided to postponed and rescheduled the Board Meeting on Friday, 25th April, 2025 at 03:00 P.M., at the registered office of the Company to discuss and consider agenda as mentioned in the attached intimation (As per BSE Announcement Dated on 18/04/2025) The Board Meeting to be held on 25/04/2025 Stands Cancelled. (As per BSE Announcement Dated on 24/04/2025) | ||
Board Meeting | 10 Apr 2025 | 3 Apr 2025 |
Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/04/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday 10th April 2025 at 03:00 P.M. at the registered office of the Company i.e. A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 inter alia to consider and approve: 1. The Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2025 along with Auditors Report. 2. Proposal of raising of funds by way of issue of Equity shares and/or Warrants on Preferential basis. 3. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting. Kindly find attached outcome (As Per Bse Announcement Dated on 10.04.2025) | ||
Board Meeting | 3 Mar 2025 | 3 Mar 2025 |
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. On 3rd March, 2025 at the Registered Office of the Company, situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060 which commenced at 4:00 P.M and concluded at 5:00 P.M. has considered and approved Unaudited Financial Results for the Half Year ended on 30th September, 2024 along with Limited Review Report. | ||
Board Meeting | 21 Jan 2025 | 21 Jan 2025 |
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. Tuesday, 21st January, 2025 at the Registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola, Ahmedabad - 380 060 which commenced at 05:00 P.M. and concluded at 07:15 P.M. has considered and approved Appointment of M/s. H Thakkar & Co. LLP, (FRN: W100891), Mumbai, as the Statutory Auditor of the Company on the recommendation of Audit Committee for the Financial Year 2024-25, subject to approval of the members in the General Meeting within three months from the date of appointment by the Board of Directors. | ||
Board Meeting | 1 Oct 2024 | 1 Oct 2024 |
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Tuesday, 1st October 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380 060 which commenced at 5:00 P.M. and concluded at 6:00 P.M., inter-alia has considered and approved: 1. Appointment of Ms. Aesha Harsh Shah (DIN: 10423365) as Additional Non-Executive Independent Director of the Company w.e.f 1st October, 2024. 2. Resignation of Mr. Pranav Manoj Vajani (DIN: 09213749) from Independent Director of the Company w.e.f 1st October, 2024. 3. Reconstitution of the Audit Committee of the Company w.e.f. 1st October, 2024 4. Reconstitution of the Nomination and Remuneration Committee of the Company w.e.f. 1st October, 2024 | ||
Board Meeting | 6 Sep 2024 | 6 Sep 2024 |
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 6th September, 2024 at A-1106, Empire Business Hub, Nr. AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat, 380060 which commenced at 05:30 P.M. and concluded at 08:30 P.M., has inter alia considered and approved as per attachment | ||
Board Meeting | 1 Aug 2024 | 1 Aug 2024 |
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e., Thursday, 1st August 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380 060 which commenced at 6:00 P.M. and concluded at 6:30 P.M., inter-alia has considered and approved 1. Appointment of Mr. Bhumishth Narendrabhai Patel (DIN: 02516641) as Managing Director of the Company w.e.f 1st August, 2024. 2. Resignation of Ms. Payal Bhumishth Patel (DIN: 05300011) from Managing Director of the Company w.e.f 1st August, 2024 | ||
Board Meeting | 22 Jun 2024 | 22 Jun 2024 |
Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd June, 2024 at the Registered Office of the Company which commenced at 02:00 P.M. and concluded at 02:30 P.M. has considered and approved Allotted 1,13,00,000 (One Crore and Thirteen Lakhs Thousand) fully paid-up Equity shares of face value of Rs. 10.00/- (Rupees Ten Only) per share, at a price of Rs. 17/- (Rupees Seventeen Only) per share, aggregating to Rs. 19,21,00,000/- (Rupees Nineteen Crore Twenty One Lakhs Only) for cash consideration to the person(s)/ entity(ies) belonging to Non-Promoter category on a preferential basis in accordance with provisions of Chapter V of SEBI (ICDR) Regulations, 2018, as mentioned in Annexure - I. | ||
Board Meeting | 27 May 2024 | 20 May 2024 |
Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a Meeting of the Board of Directors of the Company will be held on Monday 27th May 2024 at 4:00 P.M. at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380060 to consider and approve the Audited Financial Results of the Company for the Half-year and year ended on 31st March 2024 along with Auditors Report. Pursuant to Regulations 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 27th May, 2024, at the registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 04:00 P.M. and concluded at 8:00 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report. Read less.. (As Per BSE Announcement Dated on 27.05.2024) |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.